Insider · CIK 0001110780

GOLDFISCHER CARL

Reports to the SEC for 7 companies · SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001110780

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-18	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,440 sh	—	—	1,440
2024-06-20	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2023-06-14	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2022-08-12	Epizyme, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−3.38M sh	—	—	0
2022-08-12	Epizyme, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,994 sh	—	—	0
2022-08-12	Epizyme, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−13.1K sh	—	—	8,994
2022-06-14	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36K sh	—	—	36,000
2022-06-02	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2022-05-17	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,006
2022-05-17	Epizyme, Inc.A Award	Director	AAward	+8,994 sh	—	—	22,054
2021-11-17	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-06-29	ELVNEnliven Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+7,728 sh	—	—	7,728
2021-06-11	Epizyme, Inc.A Award	Director	AAward	+8,060 sh	—	—	13,060
2021-06-11	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40.6K sh	—	—	40,559
2021-05-26	DMRADamora Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2020-11-11	Epizyme, Inc.P Purchase	Director	PPurchase	+5,000 sh	$12.07	+$60.4K	5,000
2020-11-02	DMRADamora Therapeutics, Inc.C Conversion	Director	CConversion	+1.02M sh	—	—	1,020,036
2020-11-02	DMRADamora Therapeutics, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−3,688 sh	—	—	0
2020-11-02	DMRADamora Therapeutics, Inc.C Conversion	Director	CConversion	+19.4K sh	—	—	19,432
2020-11-02	DMRADamora Therapeutics, Inc. · Series C-3 Preferred StockC Conversion	Director	CConversion	−7,475 sh	—	—	0
2020-11-02	DMRADamora Therapeutics, Inc. · Series C-3 Preferred StockC Conversion	Director	CConversion	−392K sh	—	—	0
2020-11-02	DMRADamora Therapeutics, Inc.C Conversion	Director	CConversion	+9,587 sh	—	—	9,587
2020-09-25	DMRADamora Therapeutics, Inc. · Series D Preferred StockA Award	Director	AAward	+3,688 sh	$27.11	+$100K	3,688
2020-05-29	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,013
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series Seed Preferred StockC Conversion	Director	CConversion	−5,372 sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.5K sh	—	—	15,457
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−845K sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−61.4K sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−3.22M sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series Seed Preferred StockC Conversion	Director	CConversion	−282K sh	—	—	0
2020-03-16	ELVNEnliven Therapeutics, Inc.C Conversion	Director	CConversion	+13.1K sh	—	—	703,380
2020-03-16	ELVNEnliven Therapeutics, Inc.C Conversion	Director	CConversion	+690K sh	—	—	690,232
2020-03-16	ELVNEnliven Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−16.1K sh	—	—	0
2019-05-31	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,633
2019-02-07	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,335 sh	—	—	0
2019-02-07	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−11.7K sh	$9.02	−$105K	0
2019-02-07	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,335 sh	$5.00	+$11.7K	2,335
2019-02-07	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,340 sh	$5.50	+$51.4K	11,675
2019-02-07	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,340 sh	—	—	0
2019-01-29	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+27.7K sh	—	—	27,705
2018-05-18	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-03-22	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,470 sh	—	—	0
2018-03-22	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,870 sh	—	—	0
2018-03-22	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,660 sh	—	—	9,340
2018-03-22	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−15K sh	$13.03	−$195K	0
2018-03-22	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,340 sh	$5.00	+$46.7K	9,340
2018-03-22	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,660 sh	$5.50	+$31.1K	15,000
2018-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2017-11-02	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−18K sh	$8.66	−$156K	0
2017-11-02	CymaBay Therapeutics, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,000 sh	—	—	0

Recent filings

Accepted (ET)
Jun 204
GOLDFISCHER CARL0000950170-25-088162
SEC(opens sec.gov)
Jun 214
GOLDFISCHER CARL0000950170-24-076187
SEC(opens sec.gov)
Jun 154
GOLDFISCHER CARL0001209191-23-037285
SEC(opens sec.gov)
Aug 164
GOLDFISCHER CARL0000899243-22-028874
SEC(opens sec.gov)
Jun 154
GOLDFISCHER CARL0001209191-22-036932
SEC(opens sec.gov)
Jun 34
GOLDFISCHER CARL0001209191-22-034390
SEC(opens sec.gov)
May 194
GOLDFISCHER CARL0000899243-22-018818
SEC(opens sec.gov)
Nov 194
GOLDFISCHER CARL0001209191-21-065841
SEC(opens sec.gov)
Jun 304
GOLDFISCHER CARL0001209191-21-044089
SEC(opens sec.gov)
Jun 154
GOLDFISCHER CARL0000899243-21-023866
SEC(opens sec.gov)
May 284
GOLDFISCHER CARL0001209191-21-036507
SEC(opens sec.gov)
Nov 134
GOLDFISCHER CARL0000899243-20-030917
SEC(opens sec.gov)
Nov 44
GOLDFISCHER CARL0000899243-20-030416
SEC(opens sec.gov)

Companies

Address

BAY CITY CAPITAL LLC 750 BATTERY STREET

SAN FRANCISCO, CA, 94111